Ultragenyx is a biopharmaceutical company developing therapies for rare and ultra-rare genetic diseases. It creates enzyme replacement, gene, and antibody treatments targeting severe metabolic and skeletal conditions. Patients with limited options, including children and adults facing life-threatening disorders, benefit most. Healthcare providers and researchers also rely on its innovative pipeline to address unmet medical needs.
Get alerts when this topic surges in newsletters. Free to start.
Sign up freeExplore more trends:Trending Topics ·AI Trends ·Business Trends ·Finance Trends ·Technology Trends